EXPRESSION OF THE BASEMENT-MEMBRANE HEPARAN-SULFATE PROTEOGLYCAN (PERLECAN) IN HUMAN SYNOVIUM AND IN CULTURED HUMAN SYNOVIAL-CELLS

Citation
Gr. Dodge et al., EXPRESSION OF THE BASEMENT-MEMBRANE HEPARAN-SULFATE PROTEOGLYCAN (PERLECAN) IN HUMAN SYNOVIUM AND IN CULTURED HUMAN SYNOVIAL-CELLS, Laboratory investigation, 73(5), 1995, pp. 649-657
Citations number
42
Categorie Soggetti
Pathology,"Medicine, Research & Experimental
Journal title
ISSN journal
00236837
Volume
73
Issue
5
Year of publication
1995
Pages
649 - 657
Database
ISI
SICI code
0023-6837(1995)73:5<649:EOTBHP>2.0.ZU;2-Y
Abstract
BACKGROUND: Perlecan is a heparan sulfate proteoglycan that has a core protein of 466 kDa and is composed of five modules, four of which sha re a high degree of homology with a variety of biologically important molecules including the low-density lipoprotein receptor, laminin, and the neural cell adhesion molecule. Previously, this specialized prote oglycan, characteristic of the basement membrane, was not identified a s a constitutive extracellular component of human synovium. EXPERIMENT AL DESIGN: Using human synovium and cultured human synovial cells, we examined perlecan gene expression in human synovium, a tissue lacking a classic basement membrane. The modulation of gene expression of the perlecan core protein by transforming growth factor-beta (TGF-beta) an d basic fibroblast growth factor (FGF) was examined in cultures of nor mal human synovial cells, and by metabolic labeling using radioactive sodium sulfate, the question of whether this specialized protein is pr oduced by synovial cells as a proteoglycan was addressed. RESULTS: Cul tures of normal human synovial cells were shown to contain the large 1 4.5 kb perlecan mRNA and produced substantial amounts of perlecan core protein as shown by immunohistochemistry employing specific human per lecan Ab. Immunohistochemical detection showed intense staining in the intimal and subintimal layers of human synovial membrane. Moreover, t he perlecan core protein was shown to be up regulated by TGF-beta and down-regulated by basic FGF. In addition, a sizable portion (similar t o 25%) of the synovial cell-produced proteoglycan was shown to contain heparan sulfate, providing evidence that synovial cell perlecan is pr oduced as a proteoglycan. CONCLUSIONS: The presence of perlecan in hum an synovium and the modulation of the biosynthesis of its core protein by TGF-beta and FGF suggest that, in addition to its structural role, this unique heparan sulfate proteoglycan may be involved in normal sy novial membrane function and in the pathogenesis of arthritis.